Induction of the ‘ASIA’ syndrome in NZB/NZWF1 mice after injection of complete Freund’s adjuvant (CFA)

Abstract

Adjuvants, commonly used in vaccines, may be responsible for inducing autoimmunity and autoimmune diseases, both in humans and mice. The so-called ‘ASIA’ (Autoimmune/inflammatory Syndrome Induced by Adjuvants) syndrome has been recently described, which is caused by the exposure to a component reproducing the effect of adjuvants. The aim of our study was to evaluate the effect of injection of complete Freund’s adjuvant (CFA) in NZB/NZWF1 mice, a lupus-prone murine model. We injected 10 NZB/NZWF1 mice with CFA/PBS and 10 with PBS, three times, 3 weeks apart, and followed-up until natural death. CFA-injected mice developed both anti-double-stranded DNA and proteinuria earlier and at higher levels than the control group. Proteinuria-free survival rate and survival rate were significantly lower in CFA-treated mice than in the control mice (p = 0.002 and p = 0.001, respectively). Histological analyses showed a more severe glomerulonephritis in CFA-injected mice compared with the control mice. In addition, lymphoid hyperplasia in spleen and lungs, myocarditis, and vasculitis were observed in the former, but not in the latter group. In conclusion, the injection of CFA in NZB/NZWF1 mice accelerated autoimmune manifestations resembling ‘ASIA’ syndrome in humans.

Keywords

adjuvants ASIA syndrome NZB/NZWF1 mice systemic lupus erythematosus vaccines

Get full access to this article

View all access options for this article.

References

Shoenfeld

Agmon-Levin

. ‘ASIA’-Autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011; 36: 4–8.

Israeli

Agmon-Levin

Blank

Shoenfeld

. Adjuvants and autoimmunity. Lupus 2009; 18: 1217–1225.

Hornung

Bauernfeind

Halle

. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008; 9: 847–856.

Mackay

. Travels and travails of autoimmunity: a historical journey from discovery to rediscovery. Autoimmun Rev 2010; 9: A251–A258.

Schijns

VEJC

. Immunological concepts of vaccine adjuvant activity. Curr Opin Immunol 2000; 12: 456–463.

Leroux-Roels

. Unmet needs in modern vaccinology: adjuvants to improve the immune response. Vaccine 2010; 28s: C25–C36.

Rose

. Autoimmunity, infection and adjuvants. Lupus 2010; 19: 354–358.

Warchoł

Lianeri

Olesińska

Jagodziński

. Interleukin-18 promoter polymorphisms in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2011; 29: 310–313.

Lipford

Bauer

Blank

Reiter

Wagner

Heeg

. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur J Immunol 1997; 27: 2340–2344.

10.

Zorro

Arias

Riaño

. Response to ODN-CpG by B Cells from patients with systemic lupus erythematosus correlates with disease activity. Lupus 2009; 18: 718–726.

11.

Jiang

Zhao

Scearce

Diaz

. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis. Arthritis Rheum 2011; 63: 1086–1096.

12.

Eisenbarth

Colegio

O’Connor

Jr Sutterwala

Flavell

. Crucial role for the nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008; 453: 1122–1126.

13.

Tokunaga

Yano

Kuramoto

. Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol Immunol 1992; 36: 55–66.

14.

Doria

Zen

Canova

. SLE diagnosis and treatment: when early is early. Autoimmun Rev 2010; 10: 55–60.

15.

Pisetsky

Vrabie

. Antibodies to DNA: infections or genetics? Lupus 2009; 18: 1176–1180.

16.

Zandman-Goddard

Peeva

Shoenfeld

. Gender influences SLE-immune cells, genetics, experimental models and lupus patients. Clin Exp Rheumatol 2010; 28: 297–299.

17.

Ghirardello

Doria

Zampieri

. Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. J Autoimmun 2004; 22: 235–240.

18.

Festing

MFW

. Inbred strains of mice. Mouse Genome 1997; 95: 519–686.

19.

Gomez-Martin

Diaz-Zamudio

Crispin

Alcocer-Varela

. Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities. Autoimmun Rev 2009; 9: 34–39.

20.

Glück

Muller-Ladner

. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis 2008; 46: 1459–1465.

21.

Doria

Canova

Tonon

. Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev 2008; 8: 24–28.

22.

Doria

Zampieri

Sarzi-Puttini

. Exploring the complex relationships between infections and autoimmunity. Autoimmun Rev 2008; 8: 89–91.

23.

Cooke

Ferraccioli

Herrmann

. Induction and protection of autoimmune rheumatic diseases. The role of infections. Clin Exp Rheumatol 2008; 26: S1–S7.

24.

Girschick

Guilherme

Inman

. Bacterial triggers and rheumatic diseases. Clin Exp Rheumatol 2008; 26: S12–S17.

25.

Wraith

Goldman

Lambert

. Vaccination and autoimmune disease: what is the evidence? Lancet 2003; 362: 1659–1666.

26.

Schattner

. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 2005; 23: 3876–3886.

27.

Pavlovic

Kats

Cavallo

Shoenfeld

. Clinical and molecular evidence for association of SLE with parvovirus B19. Lupus 2010; 19: 783–792.

28.

Pender

. Preventing and curing multiple sclerosis by controlling Epstein–Barr virus infection. Autoimmun Rev 2009; 8: 563–568.

29.

Orbach

Agmon-Levin

Zandman-Goddard

. Vaccines and autoimmune diseases of the adult. Discov Med 2010; 9: 90–97.

30.

Geier

. A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 2005; 38: 295–301.

31.

Abu-Shakra

. Safety of vaccination of patients with systemic lupus erythematosus. Lupus 2009; 18: 1205–1208.

32.

Agmon-Levin

Paz

Israeli

Shoenfeld

. Vaccines and autoimmunity. Nat Rev Rheumatol 2009; 5: 648–652.

33.

Di Benedetto

Pierangeli

Scalise

Bertani

. Paraffin oil injection in the body: an obsolete and destructive procedure. Ann Plast Sur 2002; 49: 391–396.

34.

Anderson

Potter

. Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane). Nature 1969; 222: 994–995.

35.

Carlson

Jansson

Larsson

Buch

Lorentzen

. The endogenous adjuvant squalene can induce a chronic T-cell-mediated arthritis in rats. Am J Pathol 2000; 156: 2057–2065.

36.

Satoh

Reeves

. Induction on lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med 1994; 180: 2341–2346.

37.

Kuroda

Nacionales

Akaogi

Reeves

Satoh

. Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. Biomed Pharmacother 2004; 58: 325–337.

38.

Orbach

Tanay

. Vaccines as trigger for myopathies. Lupus 2009; 18: 1213–1216.

39.

Mikaeloff

Caridade

Suissa

Tardieu

. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 2009; 72: 873–880.

40.

Spiera

Gibofsky

Spiera

. Silicone gel filled breast implants and connective tissue disease: an overview. J Rheumatol 1994; 21: 239–245.

41.

Gherardi

. Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome. Rev Neurolog 2003; 159: 162–164.

42.

Asa

Wilson

Garry

. Antibodies to squalene in recipients of anthrax vaccine. Exp Mol Pathol 2002; 73: 19–27.

43.

Lippi

Targher

Franchini

. Vaccination, squalene and anti-squalene antibodies: facts or fiction? Eur J Intern Med 2010; 21: 70–73.

44.

Gronseth

. Gulf war syndrome: a toxic exposure? A systematic review. Neurol Clin 2005; 23: 523–540.

45.

Asa

Cao

Garry

. Antibodies to squalene in Gulf War syndrome. Exp Mol Pathol 2000; 68: 55–64.

46.

Kluger

Cohen

Fallet-Bianco

Guillevin

. Mycobacterium chelonae infection under adalimumab therapy for spondylarthritis. Clin Exp Rheumatol 2010; 28: 101–102.

47.

Yazisiz

Erbasan

Inan

. Bone marrow infection caused by Mycobacterium avium complex in a patient with systemic lupus erythematosus. Lupus 2010; 19: 323–326.

48.

Doria

Sarzi-Puttini

Shoenfeld

. Infections, rheumatism and autoimmunity: the conflicting relationship between humans and their environment. Autoimmun Rev 2008; 8: 1–4.

49.

Sarzi-Puttini

Atzeni

Iaccarino

Doria

. Environment and systemic lupus erythematosus: an overview. Autoimmunity 2005; 38: 465–472.

50.

Doria

Iaccarino

Ghirardello

. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 2006; 119: 1497–1499.

51.

Rinaldi

Doria

Salaffi

. Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age. Rheumatology 2004; 43: 1574–1579.

52.

Doria

Rinaldi

Ermani

. Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological, and psychological determinants. Rheumatology 2004; 43: 1580–1586.